Optinose Announces Reporting Date for Third Quarter 2024 Financial Results
YARDLEY, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical…
Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext…
Globus Medical Reports Third Quarter 2024 Results
AUDUBON, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:…
Ring Therapeutics Announces New Strategic Partnerships with A*STAR and SERI to Establish Gene Therapy R&D Efforts in Singapore, a Growing Global Biotech Hub
CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life…
Desert Hope Treatment Center Upgrades Veteran Addiction Care with New PsychArmor Certification
LAS VEGAS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- In recognition of the…
Algernon Announces Warrant Extension
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION…
Avicanna Announces Closing of Non-Brokered Private Placement
November 04, 2024 17:30 ET | Source: Avicanna Inc. NOT FOR DISTRIBUTION…
Biologic Pharmamedical Reveals Capryl-Butyrate and necessary lifestyle changes for natural solutions for Gut Health, Mental Clarity, and Age-Defying Wellness
VANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Biologic Pharmamedical™ Research…
Telix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals
November 03, 2024 17:03 ET | Source: Telix Pharmaceuticals Limited MELBOURNE, Australia,…
Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds
November 03, 2024 16:00 ET | Source: Belite Bio, Inc SAN DIEGO,…
